<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794996/" ref="ordinalpos=1390&amp;ncbi_uid=2098714&amp;link_uid=PMC2794996" image-link="/pmc/articles/PMC2794996/figure/F5/" class="imagepopup">Figure 5. Alteration in TLR4 <span class="highlight" style="background-color:">signaling</span> in ovarian carcinoma cell lines treated with LPS or PTX.  From: TLR4 <span class="highlight" style="background-color:">signaling</span> induced by lipopolysacharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. </a></div><br /><div class="p4l_captionBody">Western blot of the cells which were either untreated or treated with LPS or PTX for 30 and 60 min. Strong up-regulation of p-cJun was observed only in SKOV3 cells treated with LPS or PTX but not in A2780 cells, where only the TRIF pathway is activated in response to LPS or PTX signaling via the TLR4.</div></div>